Merck KGaA

DE

MRCG

Health Care

31.39 ₽

Current price

Hold
31.39 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    549 / 1328

  • Position in country

    454 / 963

  • Return on Assets, %

    5.7

    -2.7

  • Net income margin, %

    11.2

    2.8

  • EBITDA margin, %

    24.7

    10.8

  • Debt to Equity, %

    36.9

    19.2

  • Intangible assets and goodwill, %

    50.3

    3.6

  • Revenue CAGR 3Y, %

    6.1

    8.5

  • Total Equity change 1Y, %

    6.1

    0

  • Revenue Y, % chg

    -2.5

    0.5

  • P/E

    23.4

    22.7

  • P/BV

    2.4

    1.5

  • P/S

    3.1

    2.3

  • EV/S

    3.5

    2.4

  • EV/EBITDA

    12.7

    7.4

  • Average Analyst recommendation

    Strong buy

    Strong buy

  • Average upside forecasts, %

    13.2

    51.3

  • Forward P/E

    4.8

    15.6

  • Dividend Yield, %

    1.4

    1.7

  • Forward Dividend Yield, %

    5.4

    0.2

  • Expected dividend per share

    1.7

    0

  • Payout Ratio, %

    10

    30.3

  • Dividend Ex Date

    2024-04-29

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • AstraZeneca PLC

    00%

  • Bayer AG

    00%

  • Eli Lilly and Co

    00%

  • Roche Holding AG

    00%

  • Merck KGaA

    00%

  • Dermapharm Holding SE

    00%

  • Novartis AG

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Germany

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    71616.7

  • Ticker

    MKKGY.PK

  • ISIN

    US5893392093

  • IPO date

    1995-10-20

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-07

  • Date fact. publication of reports

    2023-12-31

Company Description

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.